Constellation EZH2 inhibitor (Constellation oral in vivo long-residence time EZH2 inhibitor)
< 1 minute read
Sep. 17, 2021
Constellation EZH2 inhibitor
Constellation EZH2 inhibitor
long-residence time EZH2 inhibitor oral efficacy in xenograft model from optimatization of prior EZH2 inhibitor ACS Med. Chem. Lett., Mar. 26, 2020 Constellation Pharma., Cambridge, MA
Loading...
